{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-022001","form_type":"8-K","ticker":"IONS","cik":"0000874015","company_name":"IONIS PHARMACEUTICALS INC","filed_at":"2025-06-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.535508+00:00","generated_at":"2026-05-19T16:34:09.629451+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Ionis annual meeting: all director nominees elected; equity plan increased by 4M shares","bullets":["All four director nominees elected: Diaz (134.5M for), Hayden (133.3M), Klein (127.1M), Loscalzo (108.8M).","Say-on-pay resolution approved with 132.6M votes in favor (95.9% of votes cast).","Amendment to 2011 Equity Incentive Plan approved; authorized shares increased by 4M to 42.5M.","Ratification of Ernst & Young as 2025 independent auditors approved with 144.6M votes in favor."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-022001","json":"https://secwatch.observer/filing/0001140361-25-022001.json","markdown":"https://secwatch.observer/filing/0001140361-25-022001.md","text":"https://secwatch.observer/filing/0001140361-25-022001.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/874015/000114036125022001/0001140361-25-022001-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/874015/000114036125022001/ef20050437_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T16:34:09.629451+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}